SPDR S&P Biotech ETF (NYSEARCA:XBI) Stake Cut by Johns Hopkins University

Johns Hopkins University decreased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 0.1% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 453,433 shares of the exchange traded fund’s stock after selling 318 shares during the quarter. SPDR S&P Biotech ETF accounts for 1.7% of Johns Hopkins University’s portfolio, making the stock its 10th largest position. Johns Hopkins University’s holdings in SPDR S&P Biotech ETF were worth $42,038,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in the stock. Avoro Capital Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $396,844,000. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in shares of SPDR S&P Biotech ETF by 30.3% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after purchasing an additional 730,000 shares during the period. Mirae Asset Securities USA Inc. acquired a new stake in shares of SPDR S&P Biotech ETF during the second quarter worth $55,626,000. Jane Street Group LLC grew its position in shares of SPDR S&P Biotech ETF by 68.7% in the first quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock valued at $91,197,000 after purchasing an additional 391,333 shares during the period. Finally, Baymount Management LP purchased a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at $34,160,000.

SPDR S&P Biotech ETF Trading Up 2.2 %

NYSEARCA XBI opened at $101.21 on Monday. The business’s 50-day moving average price is $98.48 and its 200 day moving average price is $93.85. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52. The company has a market capitalization of $7.71 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.